Core outcome sets and trial registries.
Core outcome sets and trial registries.
复制标题
DOI:
10.1186/s13063-015-0738-6
复制
发表时间:
2015-05-14
期刊:
影响因子:
2.5
通讯作者:
Williamson P
中科院分区:
文献类型:
--
作者:
Clarke M;Williamson P
Some reasons for registering trials might be considered as self-serving, such as satisfying the requirements of a journal in which the researchers wish to publish their eventual findings or publicising the trial to boost recruitment. Registry entries also help others, including systematic reviewers, to know about ongoing or unpublished studies and contribute to reducing research waste by making it clear what studies are ongoing. Other sources of research waste include inconsistency in outcome measurement across trials in the same area, missing data on important outcomes from some trials, and selective reporting of outcomes. One way to reduce this waste is through the use of core outcome sets: standardised sets of outcomes for research in specific areas of health and social care. These do not restrict the outcomes that will be measured, but provide the minimum to include if a trial is to be of the most use to potential users. We propose that trial registries, such as ISRCTN, encourage researchers to note their use of a core outcome set in their entry. This will help people searching for trials and those worried about selective reporting in closed trials. Trial registries can facilitate these efforts to make new trials as useful as possible and reduce waste. The outcomes section in the entry could prompt the researcher to consider using a core outcome set and facilitate the specification of that core outcome set and its component outcomes through linking to the original core outcome set. In doing this, registries will contribute to the global effort to ensure that trials answer important uncertainties, can be brought together in systematic reviews, and better serve their ultimate aim of improving health and well-being through improving health and social care.
登录
查看更多内容
影响因子:
3.7
作者:
Clarke M;Brice A;Chalmers I
通讯作者:
Chalmers I
影响因子:
3.7
作者:
Gargon E;Gurung B;Medley N;Altman DG;Blazeby JM;Clarke M;Williamson PR
通讯作者:
Williamson PR
影响因子:
2.5
作者:
Kirkham JJ;Boers M;Tugwell P;Clarke M;Williamson PR
通讯作者:
Williamson PR
影响因子:
--
作者:
Adams, Clive E;Polzmacher, Stefanie;Wolff, Annabelle
通讯作者:
Wolff, Annabelle
DOI:
10.1136/bmj.e7586
发表时间:
2013-01-08
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Chan AW;Tetzlaff JM;Gøtzsche PC;Altman DG;Mann H;Berlin JA;Dickersin K;Hróbjartsson A;Schulz KF;Parulekar WR;Krleza-Jeric K;Laupacis A;Moher D
通讯作者:
Moher D